Jeremy Moad in Oklahoma City, Oklahoma

Home Oklahoma Oklahoma City

Jeremy Moad has Pulmonary Disease as his primary medical specialty. Their primary office is: 3300 Nw Expressway in Oklahoma City, Oklahoma. There is an additional office location, for a total of two, for Jeremy Moad that can be viewed further down.

They're a part of the: Integris Ambulatory Care Corporation medical group which has around 383 members. You can call their office at 405-949-3141 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2007 (around 17 years of experience). They are listed as doing telehealth appointments.

Jeremy B Moad Office Phone and Directions

Jeremy Moad
Integris Ambulatory Care Corporation
3300 Nw Expressway
Oklahoma City, Oklahoma 73112
405-949-3141

Patient Ratings
Please rate your experience with Jeremy Moad below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 405-949-3141

Enter a starting address:

Healthcare Info for Jeremy Moad

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 2007
The Primary Medical Specialty for Jeremy Moad is listed as: Pulmonary Disease
Approximate Years of Experience: 17
PAC (PECOS ID)#: 0244411767
NPI #: 1134325608
NPI Created On: 06/22/2007
NPI Last Updated Listed as: 07/27/2023
Primary Taxonomy Code: 207R00000X
License Number:
25707
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Irrigation and suction of lung airways to obtain cells using an endoscope
Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
Test for exercise-induced lung stress
Measurement of lung diffusing capacity
New patient office or other outpatient visit, typically 30 minutes
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Critical care delivery critically ill or injured patient, first 30-74 minutes

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802901203

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802973229

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813088761

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: RESPIRATORY

Name of Drug #1: XOLAIR

Open Associated Drug #1: 50242-040-62

Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 820092489

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: GLASSIA

Open Associated Drug #1: 0944-2884-01

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 834468083

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: Sleep

Name of Drug #1: 400476/Simplus Full Face Mask- Medium

Drug or Biological: Device

Product Category #2: Sleep

Name Of Drug #2:: VIT1MA/Vitera Full Face Mask Medium

Drug or Biological #3:: Device

Product Category #3: Sleep

Name of Drug: ES2MA/ESON2 Nasal Mask Medium

Drug or Biological: Device

Product Category #4: Sleep

Name of Drug #4: EVO1MA/Evora Nasal Mask Medium

Drug or Biological #4:: Device

Product Category #5: Sleep

Name of Drug #5: BRE1SMA/Brevida Pillows Mask Fit pack

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 843521061

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Immunology

Name of Drug #1: DUPIXENT

Open Associated Drug #1: 0024-5914-01

Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 843521093

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Immunology

Name of Drug #1: DUPIXENT

Open Associated Drug #1: 0024-5914-01

Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 843521117

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Immunology

Name of Drug #1: DUPIXENT

Open Associated Drug #1: 0024-5914-01

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832550431

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CARDIOVASCULAR;METABOLIC DISEASE

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0893-21

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832719497

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CARDIOVASCULAR;METABOLIC DISEASE

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0893-21

Drug or Biological: Drug

Product Category #2: CARDIOVASCULAR

Name Of Drug #2:: VYNDAQEL

Associated Drug #2: 0069-8729-55

Additional Office Locations

1. Ou Health Partners Inc
900 Ne 10th St
Oklahoma City, OK 73104
Ouhp Family Medicine
Group Members: 805

Phone: 405-949-3141

Enter a starting address:

Pulmonary Disease Professionals in Oklahoma City

1.
Stacey Foshee

3100 Sw 89th St
Oklahoma-city, OK

2.
Gregory Mckinnis MD

608 Nw 9th St
Oklahoma-city, OK

3.
Gregory Mckinnis MD

1000 N Lee Ave
Oklahoma-city, OK
Healthfirst Physicians Management Services, Inc.

4.
Gregory Mckinnis MD

3418 Nw 135th St
Oklahoma-city, OK
Nextgen Sleep Llc

5.
Kevin Oneal

5501 N Portland
Oklahoma-city, OK
Integris Ambulatory Care Corporation

6.
Kevin Oneal

3366 Nw Expressway
Oklahoma-city, OK
Integris Ambulatory Care Corporation

Providers in Integris Ambulatory Care Corporation

1.Haley Adams

115 W 13th St
Grove Ok 74344-3224
Integris Ambulatory Care Corporation
General Surgery

2.Bilal Ahmad

4301 S Western Ave
Oklahoma City Ok 73109-3411
Integris Ambulatory Care Corporation
Hematology/oncology

3.Mohsin Ahmad

700 24th Ave Nw
Norman Ok 73069-6232
Integris Ambulatory Care Corporation
Family Practice

4.Mohsin Ahmad

3330 Nw 56th St
Oklahoma City Ok 73112-4426
Integris Ambulatory Care Corporation
Family Practice

5.Mohsin Ahmad

3400 Nw Expressway
Oklahoma City Ok 73112-4492
Integris Ambulatory Care Corporation
Family Practice

6.Shoaib Ahmad

3300 Nw Expressway
Oklahoma City Ok 73112-4418
Integris Ambulatory Care Corporation
Pulmonary Disease

View all 383 members of Integris Ambulatory Care Corporation medical group